MFDS — authorised 29 May 2013
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇰🇷 Tafinlar in South Korea
MFDS authorised Tafinlar on 29 May 2013
Marketing authorisation
Tafinlar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Tafinlar approved in South Korea?
Yes. MFDS authorised it on 29 May 2013.
Who is the marketing authorisation holder for Tafinlar in South Korea?
NOVARTIS PHARMS CORP holds the South Korean marketing authorisation.